ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "animal models and apoptosis"

  • Abstract Number: 858 • ACR/ARHP Annual Meeting 2014

    ABT-199, a Potent and Selective BCL-2 Inhibitor, Prevents Lupus Nephritis in the Spontaneous NZB/W F1 Mouse Model By Depleting Selective Lymphocyte Populations While Sparing Platelets

    Li Chun Wang1, Stuart Perper1, Annette Schwartz2, Christian Goess3, Liz O'connor4, Dawna Hartman2, Candace Graff2, Andrew Souers5, Joel Leverson5, Steven Elmore5 and Lisa Olson2, 1Immunology, AbbVie Inc, AbbVie Bioresearch Center, Worcester, MA, 2AbbVie Inc, AbbVie Bioresearch Center, Worcester, MA, 3Pharmacology, AbbVie Inc, AbbVie Bioresearch Center, Worcester, MA, 4Toxicology, AbbVie Inc, AbbVie Bioresearch Center, Worcester, MA, 5AbbVie Inc, North Chicago, IL

    Background/Purpose Proteins in the BCL-2 family are key regulators of apoptosis, or programmed cell death. Navitoclax, a selective inhibitor of both BCL-2 and BCL-X(L) demonstrated…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology